Pure Biologics Spólka Akcyjna (PUR) — Cash Flow Quality Index
Latest as of September 2017:
-0.91x
Pure Biologics Spólka Akcyjna (PUR) has a Cash Flow Quality Index of -0.91x as of September 2017. Operating cash flow of zł-182.36K is below net income of zł199.73K, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Pure Biologics Spólka Akcyjna to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.91x
Operating CF / Net Income
Operating Cash Flow
zł-182.36K
PLN
Net Income
zł199.73K
PLN
Data as of
Sep 2017
Most recent filing
Annual Cash Flow Quality Index for Pure Biologics Spólka Akcyjna (None–None)
Year-by-year earnings quality comparison for Pure Biologics Spólka Akcyjna. For live market cap and the full company financial profile, see Pure Biologics Spólka Akcyjna (PUR) total market value.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.